Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Participants in the STEP 1 trial lost an average of 10-15% of their body weight after 68 weeks, with most of the reduction occurring in the first year
We are committed to advancing science and innovation for the broader industry to open new pathways and approaches to developing treatments
The new guidelines still prioritize lifestyle changes, but they also say weight-loss medications should be offered in addition to children over 12, when the balance of risks and benefits makes sense
Lee BK, Arver S, Widman L, Gardner RM, Magnusson C, Dalman C, Kosidou K
A peer-reviewed study in the Journal of Clinical Endocrinology and Metabolism confirming that CJC-1295 produces dose-dependent increases in growth hormone and IGF-1 levels sustained over multiple days with a well-characterized safety profile in healthy adults
